Verb Technology (VERB) Stock Forecast, Price & News

0 Wall Street analysts have issued 1 year target prices for Verb Technology's shares. Their VERB share price forecasts range from $40.00 to $40.00. On average, they predict the company's share price to reach $40.00 in the next twelve months. This suggests a possible upside of 4,605.9% from the stock's current price.
View analysts price targets for VERB or view top-rated stocks among Wall Street analysts.

Verb Technology's stock was trading at $6.5640 at the beginning of the year. Since then, VERB stock has decreased by 87.1% and is now trading at $0.85.
View the best growth stocks for 2023 here.

Verb Technology saw a decline in short interest in August. As of August 31st, there was short interest totaling 81,800 shares, a decline of 53.3% from the August 15th total of 175,300 shares. Based on an average daily trading volume, of 3,140,000 shares, the short-interest ratio is presently 0.0 days. Currently, 2.2% of the shares of the stock are sold short.
View Verb Technology's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Monday, November 13th 2023.
View our VERB earnings forecast.

Verb Technology Company, Inc. (NASDAQ:VERB) issued its quarterly earnings results on Monday, August, 14th. The company reported ($0.94) earnings per share (EPS) for the quarter. Verb Technology had a negative net margin of 601.01% and a negative trailing twelve-month return on equity of 494.15%.

Shares of Verb Technology reverse split on the morning of Wednesday, April 19th 2023. The 1-40 reverse split was announced on Wednesday, April 19th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, April 19th 2023. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some companies that other Verb Technology investors own include Nokia Oyj (NOK), OPKO Health (OPK), Inovio Pharmaceuticals (INO), Tonix Pharmaceuticals (TNXP), Actinium Pharmaceuticals (ATNM), International Business Machines (IBM), Onconova Therapeutics (ONTX), Pfizer (PFE), VBI Vaccines (VBIV) and Biocept (BIOC).

Verb Technology trades on the NASDAQ under the ticker symbol "VERB."

Verb Technology's stock is owned by many different retail and institutional investors. Top institutional shareholders include BlackRock Inc. (0.71%).
View institutional ownership trends.

Shares of VERB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of VERB stock can currently be purchased for approximately $0.85.

Verb Technology (NASDAQ:VERB) has a market capitalization of $3.83 million and generates $9.44 million in revenue each year. The company earns $-37,440,000.00 in net income (profit) each year or ($13.64) on an earnings per share basis.

Verb Technology's mailing address is 2210 Newport Boulevard Suite 200, Newport Beach CA, 92663. The official website for the company is www.myverb.com. The company can be reached via phone at (855) 250-2300 or via email at valter@kcsa.com.